Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · IEX Real-Time Price · USD
7.16
-0.30 (-4.02%)
At close: Jul 2, 2024, 4:00 PM
7.18
+0.02 (0.28%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 500 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
500
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$92,470
Profits / Employee
-$708,224
Market Cap
1.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 500 | 0 | - |
Dec 31, 2022 | 500 | 100 | 25.00% |
Dec 31, 2021 | 400 | 184 | 85.19% |
Dec 31, 2020 | 216 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Evotec SE | 4,952 |
Zai Lab | 2,175 |
NeoGenomics | 2,100 |
Galapagos NV | 1,123 |
Veracyte | 815 |
Arvinas | 445 |
Ardelyx | 267 |
RXRX News
- 6 days ago - Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock - GlobeNewsWire
- 6 days ago - Recursion Announces Proposed Offering of Class A Common Stock - GlobeNewsWire
- 8 days ago - Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data - Business Wire
- 8 days ago - Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day - GlobeNewsWire
- 24 days ago - Nvidia Owns These 4 Stocks. Here's How They're Doing. - Barrons
- 4 weeks ago - Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool - GlobeNewsWire
- 5 weeks ago - Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board - GlobeNewsWire
- 7 weeks ago - Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry - GlobeNewsWire